PET/CT and contrast-enhanced CT: making a difference in assessment and staging of patients with lymphoma
Background The aim of this study is to evaluate the diagnostic performance of contrast-enhanced computed tomography (CECT) and 2-[Fluorine-18] fluoro-2-deoxy-d-glucose positron emission tomography combined to computed tomography (18 F-FDG PET/CT) in assessment of lymphoma. Methods Hundred patients,...
Saved in:
Published in: | Egyptian journal of radiology and nuclear medicine Vol. 51; no. 1; pp. 213 - 17 |
---|---|
Main Authors: | , , , |
Format: | Journal Article |
Language: | English |
Published: |
Cairo
Springer
23-10-2020
Springer Nature B.V SpringerOpen |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Background The aim of this study is to evaluate the diagnostic performance of contrast-enhanced computed tomography (CECT) and 2-[Fluorine-18] fluoro-2-deoxy-d-glucose positron emission tomography combined to computed tomography (18 F-FDG PET/CT) in assessment of lymphoma. Methods Hundred patients, pathologically proven as lymphoma, were evaluated by CECT and 18F-FDG PET/CT for initial assessment and staging of the disease. The number of lesions and the disease stage detected by each modality was calculated and further analyzed to be compared. Results 18F-FDG PET/CT diagnosed a total number of 545 lymphoma involved regions with sensitivity 96.6%, specificity 98.8%, and accuracy 99% that was higher than CECT which diagnosed a total number of 439 lymphomatous regions with sensitivity 87.5%, specificity 85.7%, and accuracy 88%. Discordant staging by both modalities was found in 23% of the patients. Lymphoma was upstaged by PET/CT in 17% of the patients; with major changes in 12% of them and downstaged in 6% of the patients. Conclusion 18F-FDG PET/CT scan has a better diagnostic performance, represented by sensitivity, specificity, and accuracy, than CECT scan in the initial assessment of lymphoma regarding its nodal and extra-nodal lesions that could lead to alteration of disease staging which in turn markedly affecting the decision of treatment regimens. |
---|---|
AbstractList | Abstract Background The aim of this study is to evaluate the diagnostic performance of contrast-enhanced computed tomography (CECT) and 2-[Fluorine-18] fluoro-2-deoxy-d-glucose positron emission tomography combined to computed tomography (18 F-FDG PET/CT) in assessment of lymphoma. Methods Hundred patients, pathologically proven as lymphoma, were evaluated by CECT and 18F-FDG PET/CT for initial assessment and staging of the disease. The number of lesions and the disease stage detected by each modality was calculated and further analyzed to be compared. Results 18F-FDG PET/CT diagnosed a total number of 545 lymphoma involved regions with sensitivity 96.6%, specificity 98.8%, and accuracy 99% that was higher than CECT which diagnosed a total number of 439 lymphomatous regions with sensitivity 87.5%, specificity 85.7%, and accuracy 88%. Discordant staging by both modalities was found in 23% of the patients. Lymphoma was upstaged by PET/CT in 17% of the patients; with major changes in 12% of them and downstaged in 6% of the patients. Conclusion 18F-FDG PET/CT scan has a better diagnostic performance, represented by sensitivity, specificity, and accuracy, than CECT scan in the initial assessment of lymphoma regarding its nodal and extra-nodal lesions that could lead to alteration of disease staging which in turn markedly affecting the decision of treatment regimens. Background The aim of this study is to evaluate the diagnostic performance of contrast-enhanced computed tomography (CECT) and 2-[Fluorine-18] fluoro-2-deoxy-d-glucose positron emission tomography combined to computed tomography (18 F-FDG PET/CT) in assessment of lymphoma. Methods Hundred patients, pathologically proven as lymphoma, were evaluated by CECT and 18F-FDG PET/CT for initial assessment and staging of the disease. The number of lesions and the disease stage detected by each modality was calculated and further analyzed to be compared. Results 18F-FDG PET/CT diagnosed a total number of 545 lymphoma involved regions with sensitivity 96.6%, specificity 98.8%, and accuracy 99% that was higher than CECT which diagnosed a total number of 439 lymphomatous regions with sensitivity 87.5%, specificity 85.7%, and accuracy 88%. Discordant staging by both modalities was found in 23% of the patients. Lymphoma was upstaged by PET/CT in 17% of the patients; with major changes in 12% of them and downstaged in 6% of the patients. Conclusion 18F-FDG PET/CT scan has a better diagnostic performance, represented by sensitivity, specificity, and accuracy, than CECT scan in the initial assessment of lymphoma regarding its nodal and extra-nodal lesions that could lead to alteration of disease staging which in turn markedly affecting the decision of treatment regimens. The aim of this study is to evaluate the diagnostic performance of contrast-enhanced computed tomography (CECT) and 2-[Fluorine-18] fluoro-2-deoxy-d-glucose positron emission tomography combined to computed tomography (18 F-FDG PET/CT) in assessment of lymphoma. Hundred patients, pathologically proven as lymphoma, were evaluated by CECT and 18F-FDG PET/CT for initial assessment and staging of the disease. The number of lesions and the disease stage detected by each modality was calculated and further analyzed to be compared. 18F-FDG PET/CT diagnosed a total number of 545 lymphoma involved regions with sensitivity 96.6%, specificity 98.8%, and accuracy 99% that was higher than CECT which diagnosed a total number of 439 lymphomatous regions with sensitivity 87.5%, specificity 85.7%, and accuracy 88%. Discordant staging by both modalities was found in 23% of the patients. Lymphoma was upstaged by PET/CT in 17% of the patients; with major changes in 12% of them and downstaged in 6% of the patients. 18F-FDG PET/CT scan has a better diagnostic performance, represented by sensitivity, specificity, and accuracy, than CECT scan in the initial assessment of lymphoma regarding its nodal and extra-nodal lesions that could lead to alteration of disease staging which in turn markedly affecting the decision of treatment regimens. BackgroundThe aim of this study is to evaluate the diagnostic performance of contrast-enhanced computed tomography (CECT) and 2-[Fluorine-18] fluoro-2-deoxy-d-glucose positron emission tomography combined to computed tomography (18 F-FDG PET/CT) in assessment of lymphoma.MethodsHundred patients, pathologically proven as lymphoma, were evaluated by CECT and 18F-FDG PET/CT for initial assessment and staging of the disease. The number of lesions and the disease stage detected by each modality was calculated and further analyzed to be compared.Results18F-FDG PET/CT diagnosed a total number of 545 lymphoma involved regions with sensitivity 96.6%, specificity 98.8%, and accuracy 99% that was higher than CECT which diagnosed a total number of 439 lymphomatous regions with sensitivity 87.5%, specificity 85.7%, and accuracy 88%. Discordant staging by both modalities was found in 23% of the patients. Lymphoma was upstaged by PET/CT in 17% of the patients; with major changes in 12% of them and downstaged in 6% of the patients.Conclusion18F-FDG PET/CT scan has a better diagnostic performance, represented by sensitivity, specificity, and accuracy, than CECT scan in the initial assessment of lymphoma regarding its nodal and extra-nodal lesions that could lead to alteration of disease staging which in turn markedly affecting the decision of treatment regimens. |
Audience | Professional Academic |
Author | Zytoon, Ashraf Anas Houseni, Mohamed Mohamed Mohamed, Hala Hafez Mostafa, Basma Adel Abd Elaziz |
Author_xml | – sequence: 1 fullname: Zytoon, Ashraf Anas – sequence: 2 fullname: Mohamed, Hala Hafez – sequence: 3 fullname: Mostafa, Basma Adel Abd Elaziz – sequence: 4 fullname: Houseni, Mohamed Mohamed |
BookMark | eNptUE1LJDEQDeKCo-sf8BTYc2u-k96bDOoKgh5mYW9NdT5mMk4ns53I4r836oIerIIqePXeo3jH6DDl5BE6o-ScUqMuiuBEyo4w0hHCX-cBWjDSk05oxQ7RgnBtOkX4nyN0WsqWtBKEUCUWaPNwtbpYrjAkh21OdYZSO582kKx3eLn6iSd4jGmNAbsYgp99O-CYMJTiS5l8qm_aUmH9SssB76HGBhf8L9YN3j1P-02e4Dv6FmBX_On_fYJ-X1-tlr-6u_ub2-XlXWdFr2rHXJCj65UWmknLHCNchlHLfiTcCgrOKToqKrVXejTWgvFeKO6CBm2EJvwE3b77ugzbYT_HCebnIUMc3oA8rweYa7Q7P1AqjeyVsTAaIQI3jhnHteNCCWAsNK8f7177Of998qUO2_w0p_b-wAxlytC-lx-sNTTTmEJuKdopFjtcKkOoNkb1jXX-Bau181NsyfsQG_5J8ALTJI-B |
CitedBy_id | crossref_primary_10_3390_hemato2040041 crossref_primary_10_1155_2022_4736455 crossref_primary_10_4236_ojmi_2021_112005 crossref_primary_10_1016_j_ejro_2024_100566 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2020 Springer The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: COPYRIGHT 2020 Springer – notice: The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S PIMPY PQEST PQQKQ PQUKI PRINS DOA |
DOI | 10.1186/s43055-020-00320-0 |
DatabaseName | ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China DOAJ Directory of Open Access Journals |
DatabaseTitle | Publicly Available Content Database ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest One Academic ProQuest Central (Alumni) |
DatabaseTitleList | Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: http://www.doaj.org/ sourceTypes: Open Website |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2090-4762 |
EndPage | 17 |
ExternalDocumentID | oai_doaj_org_article_11585968cab844f38d28d37d3464a22f A680178869 |
GeographicLocations | Egypt United States--US |
GeographicLocations_xml | – name: Egypt – name: United States--US |
GroupedDBID | --- --K 0R~ 0SF 4.4 457 6I. 7X7 8FI 8FJ AACTN AAEDT AAFWJ AAIKJ AAKKN AAYZJ ABEEZ ABMAC ABUWG ACACY ACGFS ACULB ADBBV ADEZE AFGXO AFKRA AFPKN AGHFR AHBXF AKRWK ALMA_UNASSIGNED_HOLDINGS BAWUL BCNDV BENPR C24 C6C CCPQU DIK E3Z EBS FDB FYUFA GROUPED_DOAJ HMCUK IAO IHR INH ITC IXB KQ8 O-L O9- OK1 PIMPY RSV SES SOJ UKHRP XH2 3V. 7XB 8FK AZQEC DWQXO K9. PQEST PQQKQ PQUKI PRINS |
ID | FETCH-LOGICAL-c496t-2df5bd9674725c2d2035fb759b03c41add61b6157e67b8cca8ee463df7a784703 |
IEDL.DBID | DOA |
ISSN | 0378-603X |
IngestDate | Tue Oct 22 15:15:59 EDT 2024 Thu Oct 10 20:37:48 EDT 2024 Tue Nov 19 21:09:56 EST 2024 Tue Nov 12 22:46:19 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c496t-2df5bd9674725c2d2035fb759b03c41add61b6157e67b8cca8ee463df7a784703 |
OpenAccessLink | https://doaj.org/article/11585968cab844f38d28d37d3464a22f |
PQID | 2812681995 |
PQPubID | 5758466 |
PageCount | 17 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_11585968cab844f38d28d37d3464a22f proquest_journals_2812681995 gale_infotracmisc_A680178869 gale_infotracacademiconefile_A680178869 |
PublicationCentury | 2000 |
PublicationDate | 2020-10-23 |
PublicationDateYYYYMMDD | 2020-10-23 |
PublicationDate_xml | – month: 10 year: 2020 text: 2020-10-23 day: 23 |
PublicationDecade | 2020 |
PublicationPlace | Cairo |
PublicationPlace_xml | – name: Cairo |
PublicationTitle | Egyptian journal of radiology and nuclear medicine |
PublicationYear | 2020 |
Publisher | Springer Springer Nature B.V SpringerOpen |
Publisher_xml | – name: Springer – name: Springer Nature B.V – name: SpringerOpen |
SSID | ssj0000400164 |
Score | 2.2245266 |
Snippet | Background The aim of this study is to evaluate the diagnostic performance of contrast-enhanced computed tomography (CECT) and 2-[Fluorine-18]... The aim of this study is to evaluate the diagnostic performance of contrast-enhanced computed tomography (CECT) and 2-[Fluorine-18] fluoro-2-deoxy-d-glucose... BackgroundThe aim of this study is to evaluate the diagnostic performance of contrast-enhanced computed tomography (CECT) and 2-[Fluorine-18]... Abstract Background The aim of this study is to evaluate the diagnostic performance of contrast-enhanced computed tomography (CECT) and 2-[Fluorine-18]... |
SourceID | doaj proquest gale |
SourceType | Open Website Aggregation Database |
StartPage | 213 |
SubjectTerms | 18F-FDG PET/CT: 2-[Fluorine-18] fluoro-2-deoxy-d-glucose positron emission tomography combined to computed tomography Bone marrow CECT: contrast-enhanced computed tomography CT imaging Dextrose Diabetes Diagnosis Disease Fluorides Glucose Insulin Lymphoma Medical imaging Metabolism Non-Hodgkin's lymphomas Patients PET imaging Radiation Tomography Tumors |
Title | PET/CT and contrast-enhanced CT: making a difference in assessment and staging of patients with lymphoma |
URI | https://www.proquest.com/docview/2812681995 https://doaj.org/article/11585968cab844f38d28d37d3464a22f |
Volume | 51 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LSwMxEA7WkxdRVKzWkoPgKTRNsnl4q7XiSQQreFuSTYKC3YrbHvz3TrJboQfx4nU3C8PMZB7ZyfchdGlMOq6JnFATIhFjyon2Y2hcZQXewayyLp133D-phxd9O0swOT9UX2kmrIUHbhU3gopFF0bqyjotROTaM-258lxIYRmLOfpS2TZTm1sxWo6ajGVFUndEE0k4oR0q_2-xNyeUuwO031WCeNJKcIh2Qn2EXh9n89F0jqG_x3mK3DYrEurX_J8eT-fXeJHpo7DFG2qTKuC3GtsfhM38LdR8iX0ILyPukFMbnI5c8fsXmG-5sMfo-W42n96TjgyBVMLIFWE-Fs4bCeU_KyrmGeVFdKowjvJKjCFMybGD8kQFqZwGu-gQhOQ-KqsgA1F-gnbrZR1OEVZpNRXcecYFxGprbBGp1U4UlFvH-ugmKar8aPEuyoRAnR-AXcrOLuVfdumjq6TmMu0TUFZlu3F_ECEhTpUTCbkR-m9p-miwtRL8u9p-vTFU2e2vpmRQl0idrpef_Yew52iPJU-BnMT4AO2uPtfhAvUavx6i3pSJYfaub-sP0W8 |
link.rule.ids | 315,782,786,866,2106,27933,27934 |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=PET%2FCT+and+contrast-enhanced+CT%3A+making+a+difference+in+assessment+and+staging+of+patients+with+lymphoma&rft.jtitle=Egyptian+journal+of+radiology+and+nuclear+medicine&rft.au=Zytoon%2C+Ashraf+Anas&rft.au=Mohamed%2C+Hala+Hafez&rft.au=Mostafa%2C+Basma+Adel+Abd+Elaziz&rft.au=Houseni%2C+Mohamed+Mohamed&rft.date=2020-10-23&rft.pub=Springer+Nature+B.V&rft.issn=0378-603X&rft.eissn=2090-4762&rft.volume=51&rft.issue=1&rft.spage=213&rft_id=info:doi/10.1186%2Fs43055-020-00320-0&rft.externalDBID=HAS_PDF_LINK |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0378-603X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0378-603X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0378-603X&client=summon |